Aldeyra Therapeutics announces closing of common stock offering
Aldeyra Therapeutics announced the underwriters for its recently completed underwritten public offering of common stock have purchased 122,500 additional shares from Aldeyra at the public offering price of $7.50 per share, less underwriting discounts and commissions. May 22, 2015